Innovative Start-Up award recognizes LIBERTY as a highly innovative, ground-breaking product with potentially wide range and/or substantial benefitHINGHAM, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- ...

Leading academic center with multi-hospital and multi-state health system deepens Company’s footprint in the Northeast U.S.

Microbot Medical has secured FDA authorization to move forward with the first human clinical trial of its LIBERTY ...

Harel Gadot, CEO of Microbot Medical Inc. (NASDAQ:MBOT), was recently a guest on Benzinga's All Access. Microbot Medical makes the LIBERTY® Endovascular Robotic System, a single-use, fully disposable ...

Microbot won FDA 510(k) clearance for its LIBERTY Endovascular Robotic System. MBOT shares jumped 22.9% after the announcement and are up 301.8% year to date. The LIBERTY system is compact, disposable ...

Detailed price information for Microbot Medical Inc (MBOT-Q) from The Globe and Mail including charting and trades.

Lovell Government Services will become Microbot's service-disabled veteran-owned small business vendor to supply federal ...

Detailed price information for Microbot Medical Inc (MBOT-Q) from The Globe and Mail including charting and trades.

Representing a significant advancement in healthcare, endovascular procedures performed inside blood vessels embody the intersection of medicine and technology. By addressing critical conditions such ...

Microbot Medical, a surgical robotics company, has announced the FDA approval to start its human clinical trials for the Liberty Endovascular Robotic Surgical System. The Liberty system was designed, ...

Microbot Medical Inc. MBOT recently received FDA 510(k) clearance for its LIBERTY Endovascular Robotic System, marking a major regulatory milestone for the company. The LIBERTY system is designed to ...